Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Regis Corporation
MINNEAPOLIS, Jan. 9, 2014 /PRNewswire/ -- Regis Corporation (NYSE: RGS), the global leader in the $160 billion haircare industry with brands including Supercuts, SmartStyle, MasterCuts and Regis Salons, has supported breast cancer research for more than 20 years.
This past October, which was Breast Cancer Awareness month, Regis Corporation salons, stylists, guests and business partners came together during the company's annual Clip for the Cure campaign to raise money for breast cancer research. The campaign's highlight was a daylong haircutting event held on Saturday, October 19, 2013. Stylists at over 7,000 corporate salons throughout the country gave more than 225,000 haircuts to guests, with a portion of those proceeds going to The Regis Foundation for Breast Cancer Research. In addition, guests helped raise funds by purchasing limited-edition "pink" products and donating to the cause.
After this year's Clip for the Cure campaign, The Regis Foundation for Breast Cancer Research donated $400,000 to Mayo Clinic to fight this devastating disease.
"Regis has a history of partnering with Mayo Clinic and we proudly support their groundbreaking work in breast cancer research," said Dan Hanrahan, CEO and president of Regis Corporation. "Breast cancer research is an important cause for our company because the disease touches the lives of many of our guests, stylists, team members as well as our friends and families."
One out of every eight women will develop breast cancer during her lifetime. About 75 percent of these cancers are classified as estrogen-receptor positive and are commonly treated with the drug tamoxifen. This year's Regis Foundation donation supports Matthew Goetz, M.D., a Mayo Clinic oncologist who is working with the National Cancer Institute to develop endoxifen, a drug to treat women with breast cancer that is resistant to standard hormonal based therapies.
"I am so grateful for Regis' support," Goetz said. "My colleagues and I are committed to innovative new work like this because our patients deserve the best therapies when facing a life threatening disease such as breast cancer."
Regis Corporation has supported breast cancer research since 1990, raising more than $10 million for its foundation, which funds breast cancer research at Mayo Clinic, the University of Minnesota's Masonic Cancer Center and other nationally recognized organizations. Over 30 Regis Corporation salon brands participated in the 2013 Clip for the Cure campaign including Supercuts, SmartStyle, MasterCuts and Regis Salons. For more information, visit ClipForTheCure.org.
The Regis Foundation for Breast Cancer Research
The Regis Foundation for Breast Cancer Research funds groundbreaking research at nationally recognized centers. The focus of this research is on prevention, early diagnosis, treatment and finding a cure. In addition, the Foundation supports institutions that assist and treat patients with breast cancer. Since it was founded in 1994, the Foundation has raised over $10 million.
About Regis Corporation
Regis Corporation (NYSE: RGS) is a leader in beauty salons and cosmetology education. As of September 30, 2013, the Company owned, franchised or held ownership interests in 9,752 worldwide locations. Regis' corporate and franchised locations operate under concepts such as Supercuts, SmartStyle, MasterCuts, Regis Salons, Sassoon Salon, Cost Cutters and Cool Cuts 4 Kids. Regis maintains ownership interests in Empire Education Group in the U.S. and the MY Style concepts in Japan. For additional information about the Company, including a reconciliation of certain non-GAAP financial information and certain supplemental financial information, please visit the Investor Information section of the corporate website at www.RegisCorp.com.
©2012 PR Newswire. All Rights Reserved.